Literature DB >> 17086395

Increased presence of serotonin-producing cells in colons with diverticular disease may indicate involvement in the pathophysiology of the condition.

S Banerjee1, N Akbar, J Moorhead, J A Rennie, A J M Leather, D Cooper, S Papagrigoriadis.   

Abstract

INTRODUCTION: Serotonin is an important neuroendocrine transmitter participating in the control of colonic motor activity through neural and biochemical mechanisms in the Enteric Nervous System (ENS). A possible pathophysiological factor for diverticular disease (DD) is altered colonic motility. The study compared the distribution of serotonin cells (SC) in the colonic mucosa of patients with diverticular disease to controls.
METHODS: Sixteen paraffin specimens with sigmoid diverticular disease were selected and sections of bowel without diverticula from the same specimen were used as its own control. The resection margins from sixteen colonic specimens excised for sigmoid cancer were additional controls. Immunocytochemical staining for serotonin cells was performed on 4-mum tissue sections with polyclonal antibody (NCL-SEROTp). The number of serotonin-positive cells per ten microscopic fields (x200) was assessed in all groups and the staining distribution was defined as low (0-33%), moderate (>33-66%) and high (>66%) according to the percentage of the entire cell containing contrast material. The control specimens were blinded before analysis. Student's t test was used for statistical analysis and significance level was set as P < 0.05.
RESULTS: The mean number of serotonin-positive cells per ten fields in the colonic mucosa of specimens with diverticular disease was significantly higher [252.44 (SD 90.64)] than the specimen's own control [147.31 (SD 50.16)] and at normal resection margins of cancer specimens [228.38 (SD 120.10)]. The paired analysis between diverticular disease specimens and its own control (paired t test) showed significant differences for moderate (P = 0.008), high (P = 0.001) and total (P = 0.002) number of serotonin cells. There was no evidence of significance between mean DD and cancer values. DISCUSSION: Increased presence of SCs and the higher proportion of high and moderate staining cells (indicating increased hormone content) indicate the possible role of serotonin in DD. This may be contributing to the pathogenesis of the condition by altered colonic motility in the affected segments in a similar way as in irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086395     DOI: 10.1007/s00384-006-0216-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  57 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  PATHOGENESIS OF MULTIPLE DIVERTICULA OF THE SOGMOID COLON IN DIVERTICULAR DISEASE.

Authors:  S ARFWIDSSON; N G KNOCK; L LEHMANN; T WINBERG
Journal:  Acta Chir Scand Suppl       Date:  1964

3.  The prognosis in diverticulitis of the colon.

Authors:  R W Zollinger
Journal:  Arch Surg       Date:  1968-09

Review 4.  Cyclooxygenase-2 inhibition prevents colorectal cancer: from the bench to the bed side.

Authors:  Smadar Samoha; Nadir Arber
Journal:  Oncology       Date:  2005-09-19       Impact factor: 2.935

5.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

6.  GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

Authors:  N J Talley; S F Phillips; A Haddad; L J Miller; C Twomey; A R Zinsmeister; R L MacCarty; A Ciociola
Journal:  Dig Dis Sci       Date:  1990-04       Impact factor: 3.199

7.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Authors:  S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception.

Authors:  J X Chen; H Pan; T P Rothman; P R Wade; M D Gershon
Journal:  Am J Physiol       Date:  1998-09

9.  5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.

Authors:  N Kishibayashi; Y Miwa; H Hayashi; A Ishii; S Ichikawa; H Nonaka; T Yokoyama; F Suzuki
Journal:  J Med Chem       Date:  1993-10-29       Impact factor: 7.446

10.  Effect of FK1052, a potent 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptor dual antagonist, on colonic function in vivo.

Authors:  M Kadowaki; Y Nagakura; M Tomoi; J Mori; M Kohsaka
Journal:  J Pharmacol Exp Ther       Date:  1993-07       Impact factor: 4.030

View more
  8 in total

1.  A clinicopathological study of serotonin of sigmoid colon mucosa in association with chronic symptoms in uncomplicated diverticulosis.

Authors:  S Jeyarajah; N Akbar; J Moorhead; A Haji; S Banerjee; S Papagrigoriadis
Journal:  Int J Colorectal Dis       Date:  2012-06-29       Impact factor: 2.571

2.  Are there any functional differences of the enteric nervous system between the right-sided diverticular colon and the left-sided diverticular colon? An in vitro study.

Authors:  Ryouichi Tomita
Journal:  Int J Colorectal Dis       Date:  2014-02-23       Impact factor: 2.571

3.  Diverticular disease: A therapeutic overview.

Authors:  Antonio Tursi
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-02-06

Review 4.  Epidemiology and Pathophysiology of Diverticular Disease.

Authors:  Semeret T Munie; Surya P M Nalamati
Journal:  Clin Colon Rectal Surg       Date:  2018-06-22

5.  The role of body composition in diverticular disease.

Authors:  Julia Freckelton; Darcy Holt; Adina Borsaru; StellaMay Gwini; Daniel Croagh; Gregory Moore
Journal:  Int J Colorectal Dis       Date:  2018-04-18       Impact factor: 2.571

Review 6.  Epidemiology, Pathophysiology, and Treatment of Diverticulitis.

Authors:  Lisa L Strate; Arden M Morris
Journal:  Gastroenterology       Date:  2019-01-17       Impact factor: 22.682

7.  Are there any association between colonic diverticula and bowel symptoms?(neurogastroenterol motil 2015;27:333-338).

Authors:  Jeong Eun Shin
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

8.  Does Colonic Diverticulosis Raise the Risk of Colorectal Adenoma in Patients with Colorectal Cancer?

Authors:  Yeon-Ji Kim; Dae Bum Kim; Woo Chul Chung; Ji Min Lee
Journal:  Gastroenterol Res Pract       Date:  2019-05-20       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.